Claret Asset Management’s Globus Medical GMED Stock Holding History

Claret Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$337K	Buy	3,907 +1	+0%	+$90	0.04%	162
2025 Q4	$341K	Sell	3,906 -9	-0.2%	-$683	0.04%	150
2025 Q3	$224K	Sell	3,915 -55	-1%	-$3.17K	0.03%	342
2025 Q2	$234K	Buy	3,970 +965	+32%	+$62.3K	0.03%	275
2025 Q1	$220K	Buy	3,005 +2	+0.1%	+$165	0.03%	240
2024 Q4	$248K	Buy	3,003 +20	+0.7%	+$1.58K	0.04%	174
2024 Q3	$213K	Buy	2,983 +16	+0.5%	+$1.13K	0.03%	284
2024 Q2	$203K	Buy	+2,967	New	+$177K	0.04%	200

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Claret Asset Management's GMED Position: Q1 2026 in Review

Claret Asset Management increased its Globus Medical (GMED) stake by 0.03% in Q1 2026, buying an estimated $90 and bringing the position to 3,907 shares worth $337K. The position accounts for 0.04% of the portfolio, ranked #162.

Claret Asset Management first reported a position in GMED in Q2 2024 and has held it in 8 quarters since. The position peaked at $341K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Claret Asset Management held 3,907 shares of Globus Medical worth $337K as of Q1 2026.
Claret Asset Management bought 1 Globus Medical share in Q1 2026, an estimated $90.
Globus Medical made up 0.04% of Claret Asset Management's portfolio in Q1 2026, its #162 holding.
Claret Asset Management first reported a position in Globus Medical in Q2 2024 and has held it in 8 quarters since.
Claret Asset Management's Globus Medical position peaked at $341K in Q4 2025.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.